Differential Role of Transforming Growth Factor-beta in an Osteoarthritic or a Healthy Joint
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Transforming growth factor-β (TGF-β) is a cytokine that plays an important role in both normal joints and joints affected by osteoarthritis (OA), the most common joint disease. However, the role of this pleiotropic cytokine in a normal healthy joint is very different from its role in an OA joint. In a normal synovial joint, active TGF-β is only present after joint loading and only for a short period. In contrast, permanent and high levels of active TGF-β are detected in OA joints. Due to this difference in levels and exposure period of joint cells to active TGF-β, the function of TGF-β is strikingly different in normal and OA joints. The consequences of this difference in TGF-β levels on joint homeostasis and pathological changes in OA joints are discussed in this review.
Abstract
Transforming growth factor-β (TGF-β) is a cytokine that plays an important role in both normal joints and joints affected by osteoarthritis (OA), the most common joint disease. However, the role of this pleiotropic cytokine in a normal healthy joint is very different from its role in an OA joint. In a normal synovial joint, active TGF-β is only present after joint loading and only for a short period. In contrast, permanent and high levels of active TGF-β are detected in OA joints. Due to this difference in levels and exposure period of joint cells to active TGF-β, the function of TGF-β is strikingly different in normal and OA joints. The consequences of this difference in TGF-β levels on joint homeostasis and pathological changes in OA joints are discussed in this review.
참고문헌 (68)
- Wallace IJ, "Knee osteoarthritis has doubled in prevalence since the mid-20th century", Proc Natl Acad Sci U S A, 114, pp.9332~9336 (2017)[DOI]
- Newfeld SJ, "Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers", Genetics, 152, pp.783~795 (1999)
- Dickson MC, "Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice", Development, 121, pp.1845~1854 (1995)
- Kulkarni AB, "Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death", Proc Natl Acad Sci U S A, 90, pp.770~774 (1993)[DOI]
- Shull MM, "Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease", Nature, 359, pp.693~699 (1992)[DOI]
- Sanford LP, "TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes", Development, 124, pp.2659~2670 (1997)
- Proetzel G, "Transforming growth factor-beta 3 is required for secondary palate fusion", Nat Genet, 11, pp.409~414 (1995)[DOI]
- Yingling JM, "Signaling by the transforming growth factor-beta receptors", Biochim Biophys Acta, 1242, pp.115~136 (1995)
- Itoh S, "Signaling of transforming growth factor-beta family members through Smad proteins", Eur J Biochem, 267, pp.6954~6967 (2000)[DOI]
- Finnson KW, "ALK1 opposes ALK5", Smad3 signaling and expression of extracellular matrix components in human chondrocytes, 2008, pp.23, 896~906
- Blaney Davidson EN, "Increase in ALK1", ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice, 2009, pp.182, 7937~7945
- Remst DF, "TGF-ss induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling", Cell Tissue Res, 355, pp.163~171 (2014)[DOI]
- Cao Y, "Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype", J Biol Chem, 285, pp.31840~31848 (2010)[DOI]
- Rudini N, "VE-cadherin is a critical endothelial regulator of TGF-beta signalling", EMBO J, 27, pp.993~1004 (2008)[DOI]
- Goumans MJ, "Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors", EMBO J, 21, pp.1743~1753 (2002)[DOI]
- Morales TI, "Transforming growth factor-beta in calf articular cartilage organ cultures: synthesis and distribution", Arch Biochem Biophys, 288, pp.397~405 (1991)[DOI]
- Albro MB, "Dynamic mechanical compression of devitalized articular cartilage does not activate latent TGF-beta", J Biomech, 46, pp.1433~1439 (2013)[DOI]
- Fava R, "Active and latent forms of transforming growth factor beta activity in synovial effusions", J Exp Med, 169, pp.291~296 (1989)[DOI]
- Fang PK, "Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders", J Oral Maxillofac Surg, 57, pp.922~928 (1999)[DOI]
- Zielinski S, "Evidence of proteolytic activation of transforming growth factor beta in synovial fluid", Adv Exp Med Biol, 477, pp.477~481 (2000)
- Hinz B, "The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship", Matrix Biol, 47, pp.54~65 (2015)[DOI]
- Hinz B, "Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis", Curr Rheumatol Rep, 11, pp.120~126 (2009)[DOI]
- Vanwanseele B, "Knee cartilage of spinal cord-injured patients displays progressive thinning in the absence of normal joint loading and movement", Arthritis Rheum, 46, pp.2073~2078 (2002)[DOI]
- Wang Q, "Cartilage-specific deletion of Alk5 gene results in a progressive osteoarthritis-like phenotype in mice", Osteoarthritis Cartilage, 25, pp.1868~1879 (2017)[DOI]
- Wu Q, "Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice", Arthritis Rheum, 58, pp.3132~3144 (2008)[DOI]
- Yang X, "TGF-beta", Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage, 2001, pp.153, 35~46
- Serra R, "Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis", J Cell Biol, 139, pp.541~552 (1997)[DOI]
- van de Laar IM, "Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis", Nat Genet, 43, pp.121~126 (2011)[DOI]
- Madej W, "Unloading results in rapid loss of TGFbeta signaling in articular cartilage: role of loading-induced TGFbeta signaling in maintenance of articular chondrocyte phenotype?", Osteoarthritis Cartilage, 24, pp.1807~1815 (2016)[DOI]
- Albro MB, "Accumulation of exogenous activated TGF-beta in the superficial zone of articular cartilage", Biophys J, 104, pp.1794~1804 (2013)[DOI]
- Finnson KW, "Endoglin differentially regulates TGF-beta-induced Smad2", 3 and Smad1, Osteoarthritis Cartilage, pp.2010, 18[DOI]
- Hellingman CA, "Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1", 5, Tissue Eng Part A, pp.2011, 17[DOI]
- Retting KN, "BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation", Development, 136, pp.1093~1104 (2009)[DOI]
- Valcourt U, "Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes", J Biol Chem, 277, pp.33545~33558 (2002)[DOI]
- Zhao W, "Cartilage degeneration and excessive subchondral bone formation in spontaneous osteoarthritis involves altered TGF-beta signaling", J Orthop Res, 34, pp.763~770 (2016)[DOI]
- Day JS, "Adaptation of subchondral bone in osteoarthritis", Biorheology, 41, pp.359~368 (2004)
- Coughlin TR, "The role of subchondral bone damage in post-traumatic osteoarthritis", Ann N Y Acad Sci, 1383, pp.58~66 (2016)[DOI]
- Funck-Brentano T, "Subchondral bone and osteoarthritis", Curr Opin Rheumatol, 27, pp.420~426 (2015)[DOI]
- Zgoda M, "Transforming growth factor-beta1, interleukin-1beta and collagenase activity in subchondral bone of the femur and the severity of osteoarthritis of the hip", Clin Exp Rheumatol, 23, pp.912~ (2005)
- Sakao K, "Asporin and transforming growth factor-beta gene expression in osteoblasts from subchondral bone and osteophytes in osteoarthritis", J Orthop Sci, 14, pp.738~747 (2009)[DOI]
- Hayami T, "The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model", Arthritis Rheum, 50, pp.1193~1206 (2004)[DOI]
- Zhen G, "Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis", Nat Med, 19, pp.704~712 (2013)[DOI]
- Cui Z, "Halofuginone attenuates osteoarthritis by inhibition of TGF-beta activity and H-type vessel formation in subchondral bone", Ann Rheum Dis, 75, pp.1714~1721 (2016)[DOI]
- van der Kraan PM, "Osteophytes: relevance and biology", Osteoarthritis Cartilage, 15, pp.237~244 (2007)[DOI]
- van Beuningen HM, "Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint", Lab Invest, 71, pp.279~290 (1994)
- Bakker AC, "Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation", Osteoarthritis Cartilage, 9, pp.128~136 (2001)[DOI]
- van Beuningen HM, "Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation", Osteoarthritis Cartilage, 6, pp.306~317 (1998)[DOI]
- Blaney Davidson EN, "Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation", Arthritis Rheum, 56, pp.4065~4073 (2007)[DOI]
- Scharstuhl A, "Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair", J Immunol, 169, pp.507~514 (2002)[DOI]
- Scharstuhl A, "Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta", bone morphogenetic protein inhibitors during experimental osteoarthritis, 2003, pp.48, 3442~3451
- Blaney Davidson EN, "Inducible chondrocyte-specific overexpression of BMP2 in young mice results in severe aggravation of osteophyte formation in experimental OA without altering cartilage damage", Ann Rheum Dis, 74, pp.1257~1264 (2015)[DOI]
- Iwasaki M, "Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells", Endocrinology, 132, pp.1603~1608 (1993)[DOI]
- Tuli R, "Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk", J Biol Chem, 278, pp.41227~41236 (2003)[DOI]
- Eymard F, "Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis", Ann Rheum Dis, 76, pp.1142~1148 (2017)[DOI]
- Mitrovic DR, "Synovial, articular cartilage and bone changes in rapidly destructive arthropathy (osteoarthritis) of the hip", Rheumatol Int, 12, pp.17~22 (1992)
- Blaney Davidson EN, "Connective tissue growth factor", CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage, 2006, pp.54, 1653~1661
- Remst DF, "Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis", Arthritis Rheumatol, 66, pp.647~656 (2014)
- Remst DF, "Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression", Osteoarthritis Cartilage, 21, pp.157~164 (2013)[DOI]
- Morine KJ, "Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure", Cardiovasc Pathol, 31, pp.26~33 (2017)[DOI]
- Munoz-Felix JM, "ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts", Biochim Biophys Acta, 1843, pp.1111~1122 (2014)[DOI]
- Munoz-Felix JM, "Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro", Cell Signal, 28, pp.1252~1261 (2016)[DOI]
- Burch ML, "Smad linker region phosphorylation in the regulation of extracellular matrix synthesis", Cell Mol Life Sci, 68, pp.97~107 (2011)[DOI]
- Allen JB, "Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta", J Exp Med, 171, pp.231~247 (1990)[DOI]
- Fava RA, "Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia", J Exp Med, 173, pp.1121~1132 (1991)[DOI]
- Wahl SM, "Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta", J Exp Med, 177, pp.225~230 (1993)[DOI]
- Diebold RJ, "Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated", Proc Natl Acad Sci U S A, 92, pp.12215~12219 (1995)[DOI]
- Monteleone G, "A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation", J Biol Chem, 279, pp.3925~3932 (2004)[DOI]
- Glansbeek HL, "Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints", Lab Invest, 78, pp.133~142 (1998)
